Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.65 |
| ▸ | CA1 | P00915 | 4/20 | 0.65 |
| ▸ | CA2 | P00918 | 4/20 | 0.65 |
| ▸ | CA7 | P43166 | 4/20 | 0.65 |
| ▸ | CA9 | Q16790 | 4/20 | 0.65 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.65 |
| ▸ | XDH | P47989 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.51 |
| ▸ | HPGD | P15428 | 3/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31258831 | 1.00 | CA12 (0.65) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5722171 | 0.91 | TSHR (0.57) | CA12CA1CA2CA7CA9 | |
| SCHEMBL403210 | 0.89 | CA12 (0.71) | CA12CA1CA2CA7CA9 | |
| SCHEMBL12040097 | 0.86 | CA12 (0.61) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5082071 | 0.85 | SMN1; SMN2 (0.65) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1647438 | 0.85 | CA12 (0.65) | CA12CA1CA2CA7CA9 | |
| SCHEMBL29826125 | 0.85 | CA1 (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL670644 | 0.85 | CA1 (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL4424415 | 0.84 | CA1 (0.62) | CA12CA1CA2CA7CA9 | |
| SCHEMBL7295677 | 0.82 | PKM (0.57) | MAPTHTTPKMNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 494 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118240886-A | Method for synthesizing ethyl salicylate compound by biological enzyme catalysis | 济南大学 | 2024-06-25 | — | — | CN | claimed |
| CN-116687962-A | Composition for preventing or treating diabetes and application thereof | 青岛大学 | 2023-09-05 | — | — | CN | claimed |
| CN-111471523-B | Spice composition with oxidation resistance | 安徽华业香料合肥有限公司 | 2022-12-23 | — | — | CN | claimed |
| CN-111471523-A | Spice composition with oxidation resistance | 安徽华业香料合肥有限公司 | 2020-07-31 | — | — | CN | claimed |
| US-10191398-B2 | Electrophotographic photoconductor, image forming apparatus, and process cartridge | RICOH COMPANY, LTD. (JP) | 2019-01-29 | — | — | US | claimed |
| CN-105685021-A | Insecticide mother liquor and application thereof | 中山榄菊日化实业有限公司 | 2016-06-22 | — | — | CN | claimed |
| EP-1053997-B1 | Process for the preparation of linear acrylonitril dimers | SALTIGO GMBH (DE) | 2007-02-28 | — | — | EP | claimed |
| CN-1290818-C | Method for asymmetrical hydrogen transfer of alpha-imino keton for synthesizing chirality salbutamol | UNIV EAST CHINA NORMAL (CN) | 2006-12-20 | — | — | CN | claimed |
| CN-1733701-A | Method for asymmetrical hydrogen transfer of alpha-imino keton for synthesizing chirality salbutamol | UNIV EAST CHINA NORMAL (CN) | 2006-02-15 | — | — | CN | claimed |
| EP-0763010-B1 | ENANTIOSELECTIVE PREPARATION OF OPTICALLY PURE ALBUTEROL | SEPRACOR INC (US) | 2000-08-30 | — | — | EP | claimed |
| EP-0763010-A4 | ENANTIOSELECTIVE PREPARATION OF OPTICALLY PURE ALBUTEROL | SEPRACOR INC (US) | 1997-07-16 | — | — | EP | claimed |
| EP-0763010-A1 | ENANTIOSELECTIVE PREPARATION OF OPTICALLY PURE ALBUTEROL | SEPRACOR, INC. (US) | 1997-03-19 | — | — | EP | claimed |
| WO-1995032178-A1 | ENANTIOSELECTIVE PREPARATION OF OPTICALLY PURE ALBUTEROL | SEPRACOR, INC. (US) | 1995-11-30 | — | — | WO | claimed |
| US-5399765-A | Salt formation | SEPRACOR, INC. (US) | 1995-03-21 | — | — | US | claimed |
| CN-116687962-B | Composition for preventing or treating diabetes and application thereof | QINGDAO UNIVERSITY (CN) | 2026-05-26 | — | — | CN | disclosed |
| US-12576055-B2 | Disease detection and treatment based on trimethyl-lysine levels | THE CLEVELAND CLINIC FOUNDATION (US) | 2026-03-17 | — | — | US | disclosed |
| CN-119707716-A | Preparation method of salbutamol | 浙江雅辰药物科技股份有限公司 | 2025-03-28 | — | — | CN | disclosed |
| US-4255575-A | HYPOTENSIVE, ANTISPASMODIC, ADRENERGIC BLOCKING AGENTS | RICHARDSON-MERRELL INC. (US) | 1981-03-10 | — | — | US | disclosed |
| EP-0018830-A2 | Spirobenzofuranones, their production and pharmaceutical compositions containing them | Takeda Chemical Industries, Ltd. (JP) | 1980-11-12 | — | — | EP | disclosed |
| US-4221808-A | Novel antihypertensive agent | RICHARDSON-MERRELL INC. (US) | 1980-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12576055-B2 | Disease detection and treatment based on trimethyl-lysine levels | BHMT, BHMT2, EHMT2 | CA12 1832/4885CA1 2402/4885CA2 1446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.